A phase I and pharmacokinetic (PK) study of weekly docetaxel (D), cisplatin (P), and daily capecitabine (C) (DPC) in patients with advanced solid tumors
Reddy, N. M., Zamboni, W. C., Creaven, P. J., Ramnath, N., Javle, M. M., Strychor, S., Repinski, T. V. W., Zamboni, B. A., Schwarz, J. K., French, R. A., Fakih, M. G.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article